163 related articles for article (PubMed ID: 28648494)
1. Characteristics and prevalence of Wilson's disease: A 2013 observational population-based study in France.
Poujois A; Woimant F; Samson S; Chaine P; Girardot-Tinant N; Tuppin P
Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):57-63. PubMed ID: 28648494
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database.
Daniel-Robin T; Bénichou B; Leboucher C; Blein C; Combal JP
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):101992. PubMed ID: 35793759
[TBL] [Abstract][Full Text] [Related]
3. Population-based epidemiologic study of Wilson's disease in Taiwan.
Lai CH; Tseng HF
Eur J Neurol; 2010 Jun; 17(6):830-3. PubMed ID: 20100230
[TBL] [Abstract][Full Text] [Related]
4. A population-based epidemiology of Wilson's disease in South Korea between 2010 and 2016.
Choe EJ; Choi JW; Kang M; Lee YK; Jeon HH; Park BK; Won SY; Cho YS; Seo JH; Lee CK; Chung JB
Sci Rep; 2020 Aug; 10(1):14041. PubMed ID: 32820224
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France.
Couchonnal E; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Dumortier J; Belmalih A; Poujois A; Jacquemin E; Brunet AS; Bost M; Lachaux A
J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):e80-e86. PubMed ID: 34091542
[TBL] [Abstract][Full Text] [Related]
6. Wilson's disease in southern Brazil: a 40-year follow-up study.
Bem RS; Muzzillo DA; Deguti MM; Barbosa ER; Werneck LC; Teive HA
Clinics (Sao Paulo); 2011; 66(3):411-6. PubMed ID: 21552664
[TBL] [Abstract][Full Text] [Related]
7. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
Tai CS; Wu JF; Chen HL; Hsu HY; Chang MH; Ni YH
J Formos Med Assoc; 2018 May; 117(5):421-426. PubMed ID: 28578978
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and natural history of Wilson's disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(43):7716-7726. PubMed ID: 29209112
[TBL] [Abstract][Full Text] [Related]
11. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease.
Sinha S; Taly AB; Prashanth LK; Arunodaya GR; Swamy HS
J Neurol Sci; 2004 Jan; 217(1):37-40. PubMed ID: 14675607
[TBL] [Abstract][Full Text] [Related]
12. [Wilson's disease in an adult].
Mercier-Jacquier M; Bronowicki JP; Raabe JJ; Jacquier A; Kaminsky P
Rev Med Interne; 2011 Jun; 32(6):341-6. PubMed ID: 21269740
[TBL] [Abstract][Full Text] [Related]
13. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
14. Estimating the clinical prevalence of Wilson's disease in the UK.
Wijayasiri P; Hayre J; Nicholson ES; Kaye P; Wilkes EA; Evans J; Aithal GP; Jones G; Pearce F; Aravinthan AD
JHEP Rep; 2021 Oct; 3(5):100329. PubMed ID: 34381985
[TBL] [Abstract][Full Text] [Related]
15. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
16. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
[TBL] [Abstract][Full Text] [Related]
17. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.
Durand F; Bernuau J; Giostra E; Mentha G; Shouval D; Degott C; Benhamou JP; Valla D
Gut; 2001 Jun; 48(6):849-52. PubMed ID: 11358907
[TBL] [Abstract][Full Text] [Related]
18. Long term results of liver transplantation for Wilson's disease: experience in France.
Guillaud O; Dumortier J; Sobesky R; Debray D; Wolf P; Vanlemmens C; Durand F; Calmus Y; Duvoux C; Dharancy S; Kamar N; Boudjema K; Bernard PH; Pageaux GP; Salamé E; Gugenheim J; Lachaux A; Habes D; Radenne S; Hardwigsen J; Chazouillères O; Trocello JM; Woimant F; Ichai P; Branchereau S; Soubrane O; Castaing D; Jacquemin E; Samuel D; Duclos-Vallée JC
J Hepatol; 2014 Mar; 60(3):579-89. PubMed ID: 24211743
[TBL] [Abstract][Full Text] [Related]
19. The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.
Xu R; Jiang YF; Zhang YH; Yang X
PLoS One; 2018; 13(1):e0190887. PubMed ID: 29324775
[TBL] [Abstract][Full Text] [Related]
20. Estimating the prevalence of depression associated with healthcare use in France using administrative databases.
Filipovic-Pierucci A; Samson S; Fagot JP; Fagot-Campagna A
BMC Psychiatry; 2017 Jan; 17(1):1. PubMed ID: 28049496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
